Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
CA 2451569 A1 · Owner: Vainio, Petri · Inventors: Smith, David John; Lazar, Laszlo; Alaranta, Sakari
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to carbocyclic hydrazino compounds that function as inhibitors of copper-containing amine oxidases commonly known as semicarbazide-sensitive amine oxidases (SSAO) including the human SSAO known , as Vascular Adhesion Protein-1 (VAP-1). These SSAO inhibitors have therapeutic utility as drugs to treat conditions and diseases including but not limited , to, a number of inflammatory conditions and diseases (in particular chronic inflammatory conditions such as chronic arthritis inflammatory bowel , diseases, and chronic skin dermatoses) diseases related to carbohydrate , metabolism and to aberrations in adipocyte differentiation or function and smooth …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 11, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 11, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 11, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.